BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23255921)

  • 1. Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors.
    Carlsson J; Shen L; Xiang J; Xu J; Wei Q
    Oncol Lett; 2013 Jan; 5(1):208-214. PubMed ID: 23255921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
    Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
    Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.
    Wei Q; Chen L; Sheng L; Nordgren H; Wester K; Carlsson J
    Int J Oncol; 2007 Sep; 31(3):493-9. PubMed ID: 17671674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
    Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
    BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
    Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
    Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides.
    Carlsson J; Wester K; De La Torre M; Malmström PU; Gårdmark T
    Radiol Oncol; 2015 Mar; 49(1):50-8. PubMed ID: 25810701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: possible implications for targeted therapy.
    Shang J; Shui Y; Sheng L; Wang K; Hu Q; Wei Q
    Oncol Rep; 2008 Feb; 19(2):435-40. PubMed ID: 18202792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy.
    Rao C; Hu Q; Ma J; Li J; Zhang C; Shen L; Wei Q
    J Exp Clin Cancer Res; 2010 Jan; 29(1):7. PubMed ID: 20096104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.
    Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
    Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.
    Poovassery JS; Kang JC; Kim D; Ober RJ; Ward ES
    Int J Cancer; 2015 Jul; 137(2):267-77. PubMed ID: 25471734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of HER3 by a novel antisense oligonucleotide, EZN-3920, improves the antitumor activity of EGFR and HER2 tyrosine kinase inhibitors in animal models.
    Wu Y; Zhang Y; Wang M; Li Q; Qu Z; Shi V; Kraft P; Kim S; Gao Y; Pak J; Youngster S; Horak ID; Greenberger LM
    Mol Cancer Ther; 2013 Apr; 12(4):427-37. PubMed ID: 23395887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.
    Chan E; Alkhasawneh A; Duckworth LV; Aijaz T; Toro TZ; Lu X; Hughes SJ; Collinsworth A; George TJ
    J Gastrointest Oncol; 2016 Dec; 7(6):838-847. PubMed ID: 28078108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
    Fichter CD; Timme S; Braun JA; Gudernatsch V; Schöpflin A; Bogatyreva L; Geddert H; Faller G; Klimstra D; Tang L; Hauschke D; Werner M; Lassmann S
    Int J Cancer; 2014 Oct; 135(7):1517-30. PubMed ID: 24510732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Suda T; Saito Y; Norizoe C; Kato T; Moriyama H; Urashima M
    Clin Exp Metastasis; 2012 Jan; 29(1):19-25. PubMed ID: 21953075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
    Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
    Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.
    Carlsson J; Nordgren H; Sjöström J; Wester K; Villman K; Bengtsson NO; Ostenstad B; Lundqvist H; Blomqvist C
    Br J Cancer; 2004 Jun; 90(12):2344-8. PubMed ID: 15150568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
    Berghoff AS; Bartsch R; Preusser M; Ricken G; Steger GG; Bago-Horvath Z; Rudas M; Streubel B; Dubsky P; Gnant M; Fitzal F; Zielinski CC; Birner P
    Breast; 2014 Oct; 23(5):637-43. PubMed ID: 25017122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer.
    Pellas U; Bauer A; Baroš IV; Fattorini C; Tot T
    Front Oncol; 2023; 13():1167567. PubMed ID: 37483511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
    Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
    Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.